- Home
- CPOP vs TENX Comparison
CPOP vs TENX Comparison
Compare CPOP & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPOP
- TENX
- Stock Information
- Founded
- CPOP 2007
- TENX 1967
- Country
- CPOP China
- TENX United States
- Employees
- CPOP N/A
- TENX N/A
- Industry
- CPOP Services-Misc. Amusement & Recreation
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- CPOP Consumer Discretionary
- TENX Health Care
- Exchange
- CPOP Nasdaq
- TENX Nasdaq
- Market Cap
- CPOP 22.7M
- TENX 21.7M
- IPO Year
- CPOP 2021
- TENX N/A
- Fundamental
- Price
- CPOP $0.72
- TENX $6.75
- Analyst Decision
- CPOP
- TENX Strong Buy
- Analyst Count
- CPOP 0
- TENX 4
- Target Price
- CPOP N/A
- TENX $20.67
- AVG Volume (30 Days)
- CPOP 250.3K
- TENX 28.4K
- Earning Date
- CPOP 11-15-2024
- TENX 03-27-2025
- Dividend Yield
- CPOP N/A
- TENX N/A
- EPS Growth
- CPOP N/A
- TENX N/A
- EPS
- CPOP N/A
- TENX N/A
- Revenue
- CPOP $47,381,918.00
- TENX N/A
- Revenue This Year
- CPOP N/A
- TENX N/A
- Revenue Next Year
- CPOP N/A
- TENX N/A
- P/E Ratio
- CPOP N/A
- TENX N/A
- Revenue Growth
- CPOP 155.52
- TENX N/A
- 52 Week Low
- CPOP $0.61
- TENX $2.77
- 52 Week High
- CPOP $9.67
- TENX $21.46
- Technical
- Relative Strength Index (RSI)
- CPOP 30.01
- TENX 64.03
- Support Level
- CPOP $0.61
- TENX $5.85
- Resistance Level
- CPOP $1.29
- TENX $6.40
- Average True Range (ATR)
- CPOP 0.11
- TENX 0.33
- MACD
- CPOP -0.05
- TENX -0.04
- Stochastic Oscillator
- CPOP 16.18
- TENX 79.66
About CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.